Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vincent-Viry

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|February 1, 1993
Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian populationC Mura, N Gerard, M Vincent-Viry, et al.
Atherosclerosis|March 20, 2001
Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphismM Starck, F Schiele, B Herbeth, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2000
Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responsesG Siest, P Bertrand, B Herbeth, et al.
Human Genetics|October 1, 1993
DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisersC Mura, S Panserat, M Vincent-Viry, et al.
Annals of Human Genetics|November 1, 1996
Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele?K Bohnet, A Regis-Bailly, M Vincent-Viry, et al.
British Journal of Clinical Pharmacology|October 1, 1995
An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotypeS Panserat, C Mura, N Gérard, et al.
Human Genetics|October 1, 1994
DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisersS Panserat, C Mura, N Gérard, et al.
Pharmacogenetics|February 1, 1995
Lack of a genetic polymorphism in the glucuronidation of fenofibric acidM Vincent-Viry, C Cossy, M M Galteau, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 1994
Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferasesA M Batt, J Magdalou, M Vincent-Viry, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?H F Liu, M Vincent-Viry, M M Galteau, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|February 1, 1993
Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian populationC Mura, N Gerard, M Vincent-Viry, et al.
Atherosclerosis|March 20, 2001
Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphismM Starck, F Schiele, B Herbeth, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2000
Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responsesG Siest, P Bertrand, B Herbeth, et al.
Human Genetics|October 1, 1993
DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisersC Mura, S Panserat, M Vincent-Viry, et al.
Annals of Human Genetics|November 1, 1996
Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS Cohort Study--dominance of the epsilon 2 allele?K Bohnet, A Regis-Bailly, M Vincent-Viry, et al.
British Journal of Clinical Pharmacology|October 1, 1995
An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotypeS Panserat, C Mura, N Gérard, et al.
Human Genetics|October 1, 1994
DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisersS Panserat, C Mura, N Gérard, et al.
Pharmacogenetics|February 1, 1995
Lack of a genetic polymorphism in the glucuronidation of fenofibric acidM Vincent-Viry, C Cossy, M M Galteau, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 1994
Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferasesA M Batt, J Magdalou, M Vincent-Viry, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?H F Liu, M Vincent-Viry, M M Galteau, et al.
Pageof 4